Procurement Summary
Country: Argentina
Summary: Acquisition of Inputs - Annex Ii
Deadline: 16 Apr 2026
Posting Date: 13 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139446591
Document Ref. No.: 401-0482-LPU26
Competition: NCB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: ARS 547678808.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
ATOSIBAN. Model: 37.5 mg (as free base), injectable, in 5 ml vial, intravenous use, ATOSIBAN. Model: 6.75 mg (as free base), injectable, in vial bottle x 0.9 ml, intravenous use, PHYSIOLOGICAL HEMOSTATIC ADHESIVE. Model: Sealer fibrinogen and factor XIII protein, aprotinin solution, lyophilized thrombin and calcium solution, chloride, in kit x 1 ml, BOTULINUM TOXIN TYPE A. Model: 100 IU, injectable, lyophilized, in a bottle bottle
File number: EX-2026-13963366- -GCABA-DGACSA Legal framework: Law No. 2, 095 (Consolidated Text by Law No. 6, 588) and Decree No. 129/23 Art. 32 Other conditions: Requires technical advice Responsible area: Technical Support Operational Deputy Manager More info: Place of receipt of physical documentation: Rivadavia 524, 4th floor, DGACSA Office
Documents
Tender Notice